[email protected] Hi, EFTA00668688 Just keeping you posted on my client's TBI pharmaceutical. Attached is a news release from my client NeuroVive Pharma. Their news focuses on their pharmaceuticals in heart attack (reperfusion injury) and traumatic brain injury. Both are currently in phase III and p